Clinical Trials Logo

Clinical Trial Summary

An open-label, randomized, single-dose, 2X3X3 partial replicate, crossover study to compare the pharmacokinetics and safety between a fixed dose combination of Fimasartan/Amlodipine/Rosuvastatin and Co-administration of a fixed dose combination of Fimasartan/Amlodipine and Rosuvastatin in healthy male subjects.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT02995720
Study type Interventional
Source Boryung Pharmaceutical Co., Ltd
Status Completed
Phase Phase 1
Start date August 26, 2016
Completion date May 30, 2017

See also
  Status Clinical Trial Phase
Completed NCT01918709 - Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers Phase 1
Active, not recruiting NCT03847506 - Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets Phase 4
Completed NCT02994745 - A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers. Phase 1